Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Repurchased
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Change in Receivables (2016 - 2026)

Pharma-Bio Serv filings provide 17 years of Change in Receivables readings, the most recent being $277116.0 for Q1 2026.

  • On a quarterly basis, Change in Receivables rose 48.7% to $277116.0 in Q1 2026 year-over-year; TTM through Jan 2026 was -$112892.0, a 138.85% decrease, with the full-year FY2025 number at -$203643.0, up 86.02% from a year prior.
  • Change in Receivables hit $277116.0 in Q1 2026 for Pharma-Bio Serv, down from $347839.0 in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $663696.0 in Q2 2023 to a low of -$1.6 million in Q1 2024.
  • Median Change in Receivables over the past 5 years was $186365.0 (2025), compared with a mean of -$74440.8.
  • The widest YoY moves for Change in Receivables: up 489.17% in 2025, down 4189.74% in 2025.
  • Pharma-Bio Serv's Change in Receivables stood at -$205939.0 in 2022, then plummeted by 650.94% to -$1.5 million in 2023, then skyrocketed by 94.22% to -$89380.0 in 2024, then soared by 489.17% to $347839.0 in 2025, then fell by 20.33% to $277116.0 in 2026.
  • The last three reported values for Change in Receivables were $277116.0 (Q1 2026), $347839.0 (Q4 2025), and -$675376.0 (Q3 2025) per Business Quant data.